Trident Alumina Insert (625-0T-XXX); Osteonics ABC/Trident System
HOWMEDICA OSTEONICS CORP · Decision date Sep 17, 2025
What did the FDA decide?
FDA records P000013/S027 as a supplement to PMA P000013, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 17, 2025.
FDA approval order statement
the use of alternative sources for some of the ingredients which are part of the composition of the adhesive coating, TPT-0260, in the Tyvek packaging for the Osteonics ABC/Trident System / Trident Alumina Insert
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 17, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P000013/S027
- Regulatory pathway
- PMA supplement
- Applicant
- HOWMEDICA OSTEONICS CORP
- Product code
- MRA
- Decision code
- OK30
- Decision date
- Sep 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented.
- Applicant
- HOWMEDICA OSTEONICS CORP
- Product code
- MRA
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P000013/S027 received
Application receipt date recorded by FDA.
P000013/S027 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P000013. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code MRA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CERAMAX CERAMIC HIP SYSTEMP070026/S129 | Depuy Orthopaedics, Inc. | PMA supplement | Sep 4, 2026 | FDA |
CERAMAX Ceramic Hip SystemP070026/S130 | Depuy Orthopaedics, Inc. | PMA supplement | Aug 27, 2026 | FDA |
CERAMAX Ceramic Total Hip SystemP070026/S128 | Depuy Orthopaedics, Inc. | PMA supplement | Jul 24, 2026 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S127 | Depuy Orthopaedics, Inc. | PMA supplement | Jun 3, 2026 | FDA |
Ceramax Ceramic Hip SystemP070026/S125 | Depuy Orthopaedics, Inc. | PMA supplement | Apr 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
HOWMEDICA OSTEONICS CORP
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 325 Corporate Dr., Mahwah, NJ, 07430
Sources and methodology
- Original FDA record: P000013/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


